To determine whether Apatinib modulates liposarcoma cell proliferation through the RRM2/PI3K/AKT pathway, we used WB to measure the protein levels of RRM2, PI3K, p-PI3K, AKT, p-AKT, mTOR, and p-mTOR. Here, AKT1 is linked to liposarcoma.